TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/20 21:31 | 5/4/20 | STML | Stemline Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Francomano Robert | NY | O | Chief Co | S | -3 | 11.51 | 0 | 0 | 0 | 198 | D | ||||||||||||||
3/13/20 21:31 | 3/9/20 | STML | Stemline Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Francomano Robert | NY | O | Chief Co | S | -6 | 5.00 | 0 | -1 | -1 | 198 | D | ||||||||||||||
2/14/20 21:29 | 2/7/20 | STML | Stemline Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Francomano Robert | NY | O | Chief Co | S | -34 | 6.72 | 0 | -5 | -2 | 199 | D | ||||||||||||||
1/3/20 17:17 | 12/23/19 | STML | Stemline Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Francomano Robert | NY | O | Chief Co | S.m | -29 | 10.84 | 0 | -3 | -3 | 98 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |